Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Efficacy and Safety of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
Authors not listed
Revance Therapeutics, Inc. · 2013
Abstract
This study will confirm the efficacy and safety of a single topical administration of botulinum toxin type A compared to placebo control for the treatment of moderate to severe crow's feet lines
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-11 MST
Cite this
APA
Anonymous. (2013). Efficacy and Safety of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines. <em>Revance Therapeutics, Inc.</em>. https://clinicaltrials.gov/study/NCT01940991
Vancouver
Anonymous. Efficacy and Safety of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines. Revance Therapeutics, Inc.. 2013.
BibTeX
@misc{anon2013Effica,
title = {Efficacy and Safety of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines},
author = {Anonymous},
journal = {Revance Therapeutics, Inc.},
year = {2013},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Revance Therapeutics, Inc. 2015
Open access · US-GOV
Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Lateral Canthal Lines
Biolab Sanus Farmaceutica 2009
Open access · US-GOV
Phase III Open Label Clinical Trial to Assess Efficacy, Safety and Tolerability of Botulinum Toxin A (Xeomin®) in Treatment of Expression Wrinkles in the Upper Third of the Face
Pfizer 2008
Open access · US-GOV
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy And Safety Trial Of Bapineuzumab (Aab-001, Eln115727) In Subjects With Mild to Moderate Alzheimer Disease Who Are Apolipoprotein E 4 Non-carriers
Istituto Oncologico Veneto IRCCS 2019
Open access · US-GOV
Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma: Observational Study
Revision Skincare 2019
Open access · US-GOV
A Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of an Anti-Aging Serum in the Treatment of Facial Lines
Seattle Institute for Biomedical and Clinical Research 2002
Open access · US-GOV